lung cancer drug Keytruda

News

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England.

News

Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.